OKYO · Categories · Form 4
OKYO - SEC Form 4 insider transactions
OKYO Pharma Limited (OKYO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for OKYO
- Chief Scientific Officer Patil Rajkumar V. was granted 3,363 shares, increasing direct ownership by 20% to 20,030 units (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)
- CHIEF EXECUTIVE OFFICER Dempsey Robert John was granted 15,000 shares (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)
- Director Brancaccio John P was granted 5,000 shares, increasing direct ownership by 17% to 35,201 units (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)
- Director Cerrone Gabriele M was granted 22,500 shares (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)
- CHIEF DEVELOPMENT OFFICER Jacob Gary S was granted 3,500 shares, increasing direct ownership by 3% to 112,420 units (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)
- CHIEF MEDICAL OFFICER Mantelli Flavio was granted 20,000 shares (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)
- Director Cerrone Gabriele M was granted 25,000 shares (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)
- SEC Form 4 filed by Director Brancaccio John P4 - OKYO Pharma Ltd (0001849296) (Issuer)
- SEC Form 4 filed by Director Denoyer Bernard4 - OKYO Pharma Ltd (0001849296) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Shah Keeren Rameshchandra4 - OKYO Pharma Ltd (0001849296) (Issuer)
- SEC Form 4 filed by Director Simon Willy Jules4 - OKYO Pharma Ltd (0001849296) (Issuer)
- Director Cerrone Gabriele M was granted 300,000 shares (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)
- Cerrone Gabriele M acquired $854,308 worth of Ordinary Shares (569,539 units at $1.50) (SEC Form 4)4 - OKYO Pharma Ltd (0001849296) (Issuer)